Abstract
Gastric cancer has continued to rise in the elderly as life expectancies increase. The current standard of care practices is often based on clinical trials consisting of much younger patient population and these treatment guidelines need to be assessed for their direct applicability to the elderly population, both in the context of their increased comorbidities as well as differences in their disease pathophysiology and presentation. This article reviews the current state of medical knowledge in the management of gastric cancer and presents evidence from the National Cancer Database (NCDB), with a special focus on the additional considerations that need to be made in the treatment of elderly patients with gastric cancer.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
